Candriam Equities L Biotechnology Class R2 USD Dis Fonds 32290054 / LU1397644631
USD
-
USD
-
%
| prices | charts | basic claims data | business ratio | action |
|---|---|---|---|---|
| snapshot | price chart | data + charge | performance | portfolio#add_instrument_to#depot |
| stock exchange | performance | management | volatility | portfolio#add_instrument_to#watchlist |
| historic | benchmark | documents | sharpe ratio | |
| returns | ratings |
prices
charts
basic claims data
business ratio
management charges
| administration fee | % |
| custodian fee | % |
| management charge | 0.38 % |
| total expense ratio (ter) | 0.71 |
| issue charge | 3.50 % |
derivatives#masterdata#headline
| issue date | 01.08.2016 |
| benchmark | NASDAQ Biotechnology |
| domicile | Luxembourg |
fund manager
| fund manager | Linden Thomson, Servaas Michielssens |
buy information
| initial minimum savings amount | |
| capital forming savings possible? | no |
investment company information
| funds#investmentcompanyinformation#adress |
Candriam Candriam Luxembourg L – 8009 Strassen |